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Abstract
Mammalian constitutive photomorphogenic 1 (COP1) is a p53 E3 ubiquitin ligase involved in regulating p53 pro-
tein level. In plants, the dynamic cytoplasm/nucleus distribution of COP1 is important for its function in terms of
catalyzing the degradation of target proteins. In mammalian cells, the biological consequence of cytoplasmic distri-
bution of COP1 is not well characterized. Here, we show that DNA damage leads to the redistribution of COP1 to
the cytoplasm and that 14-3-3s, a p53 target gene product, controls COP1 subcellular localization. Investigation of
the underlying mechanism suggests that COP1 S387 phosphorylation is required for COP1 to bind 14-3-3s. Signifi-
cantly, upon DNA damage, 14-3-3s binds to phosphorylated COP1 at S387, resulting in COP1’s accumulation in the
cytoplasm. Cytoplasmic COP1 localization leads to its enhanced ubiquitination. We also show that N-terminal 14-3-
3s interacts with COP1 and promotes COP1 nuclear export through its NES sequence. Further, we show that COP1
is important in causing p53 nuclear exclusion. Finally, we demonstrate that 14-3-3s targets COP1 for nuclear
export, thereby preventing COP1-mediated p53 nuclear export. Together, these results define a novel, detailed
mechanism for the subcellular localization and regulation of COP1 after DNA damage and provide a mechanistic
explanation for the notion that 14-3-3s’s impact on the inhibition of p53 E3 ligases is an important step for p53
stabilization after DNA damage.
Background
Mammalian constitutive photomorphogenic 1 (COP1) is
an evolutionarily conserved E3 ubiquitin ligase contain-
ing a RING-finger, a coiled-coil and WD40-repeat
domains. COP1 is a crucial mediator to block photo-
morphogenesis in the dark through the ubiquitinated
proteasomal degradation of light-induced transcription
factor HY5 [1]. In mammalian cells, COP1 regulates var-
ious cellular functions, such as proliferation and survi-
val, by facilitating the degradation of physiological
substrates through ubiquitin-mediated protein degrada-
tion. The ubiquitinated targets of COP1 include stress-
responsive transcription factors, p53 tumor suppressor
[2], c-JUN [3-5], transducer of regulated CREB activity 2
(TORC2, a glucose metabolite regulator) [6], FOXO1 [7]
and nucleosome remodeling factor MTA1 [8]. It has
been shown that DNA damage leads to COP1 nuclear
exclusion, [9,10] however, there is a knowledge gap
about how DNA damage regulates COP1’s translocation
from the nucleus to the cytoplasm.
The 14-3-3 proteins are a family of evolutionarily con-
served regulatory chaperone molecules involved in many
diverse physiological functions, including signal trans-
duction, stress response, apoptosis and cell cycle check-
point regulation [10,11]. In mammals, the 14-3-3 family
comprises seven isoforms: b, ε, g, ζ, h, s,a n dτ,w h i c h
are widely expressed in various tissues and exert their
biological functions by directly binding to phosphopro-
teins containing the consensus motif RX (Y/F) XpSXP
or RSXpSXP. This binding alters the proteins stability
and/or subcellular localization [12]. 14-3-3s was origin-
ally characterized as a human mammary epithelial-speci-
fic marker (HME1) [13], and was later found to be an
essential regulator of apoptosis, cell migration, cell cycle
and DNA damage response. In contrast to the other 14-
3-3 family members (b, ε, g, ζ, h,a n dτ), which are able
to form both homo- and heterodimers with other
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unique characteristic implies that 14-3-3s has exclusive
functions and behaviors. 14-3-3s, but not other family
members, has been found to be frequently lost or
decreased in various human cancers [15] and functions
as a potential tumor suppressor. 14-3-3s negatively
represses AKT-induced MDM2 activation by promoting
the cytoplasmic translocati o no fM D M 2a n dt r i g g e r i n g
its degradation [10,16,17]. 14-3-3s also directly inhibits
AKT-mediated tumor progression through binding-
mediated suppression of AKT kinase activity [18]. 14-3-
3s also obstructs cell cycle progression and prevents
tumor cell growth by inhibiting cyclin-CDK complex
activity [19]. In the DNA damage response, 14-3-3s is
known to be a p53 downstream target and may serve as
a regulator to prevent oxidative and DNA-damaging
stress-induced mitotic checkpoint dysfunction [20].
Although 14-3-3s may play an important role in pro-
tecting cells from DNA damage, the detailed mechanism
by which 14-3-3s modulates the DNA damage response
is not well characterized.
In this study, we examined the role of 14-3-3s in
DNA damage-mediated COP1 sub-cellular localization.
We found that DNA damage induced COP1 nuclear
exclusion, and that this phenomenon was abrogated in
14-3-3s-null or -knockdown cells. Further investigation
revealed that 14-3-3s physically interacted with COP1
through an ATM phosphorylation site, which is phos-
phorylated in response to DNA damage. Importantly,
14-3-3s utilizes its NES to mediate COP1 nuclear
export, which leads to enhanced COP1 ubiquitination.
Furthermore, 14-3-3s was shown to not only mediate
COP1 nuclear export but also repress COP1-mediated
p53 nuclear export. Thus, our studies of 14-3-3s’s
impact on COP1-shuttling provide mechanistic insight
into COP1 localization and p53 regulation during DNA
damage.
Results
14-3-3s is involved in DNA damage-induced COP1
nuclear exclusion
COP1 dynamically migrates from the cytoplasm to the
nucleus. This process is important to regulation of
COP1’s target proteins. DNA damage induces both p53
activation and COP1 subcellular shuttling from the
nucleus to the cytoplasm. However, the underlying
mechanism of DNA damage-induced COP1 cytoplasmic
translocation is unknown. We performed live-cell ima-
ging of NIH3T3 cells stably expressing RFP-COP1 and
found punctate COP1 staining expression in both the
nucleus and the cytoplasm (Figure 1A). Time-lapse con-
focal microscopy showed that COP1 could shuttle
between the cytoplasm and the nucleus under non-
stressed conditions (Figure 1B, upper panel). However,
COP1’s dynamic nucleus/cytoplasm shuttling was
impaired in cells with DNA damage induced by ionizing
radiation (IR, 10 Gy) (Figure 1B, bottom panel). We
confirmed this observation in U2OS cells in the pre-
sence of IR or Doxorubicin.
Subcellular fractionation (Lamin B1 was used as the
marker of nuclear (N) fraction, while a-tubulin was
used as the marker for cytoplasmic fraction) followed by
Western blot analysis confirmed that the proportion of
COP1 in the cytoplasmic fraction increased in DNA
damaged cells (treated with doxorubicin or IR) com-
pared with untreated controls (Figure 1C). Given that
14-3-3s can be induced by DNA damaging agents and
that 14-3-3s exerts its influence by regulating the sub-
cellular localization of its targets [19,21], we then sought
to determine whether 14-3-3s expression can affect the
subcellular location of COP1. Time-lapse confocal
microscopy demonstrated that RFP-COP1 is dynamically
shuttled between the nucleus and the cytoplasm in RFP-
COP1-overexpressing cells infected with Ad-bgal, but
this dynamic shuttling of COP1 was compromised when
cells were infected with adenovirus containing14-3-3s
(Ad-14-3-3s; Figure 1D). Subcellular fractionation fol-
lowed by Western blot analysis again confirmed that the
proportion of COP1 in the cytoplasmic fraction
increased in Ad-14-3-3s infected cells compared with
Ad-bgal infected controls (Figure 1D). Thus, 14-3-3s
inhibited the dynamic shuttling of COP1 into the
nucleus, concurrent with the increase of COP1 cytoplas-
mic staining.
COP1 S387 phosphorylation is essential for 14-3-3s-
induced COP1 nuclear export
Next, we examined the specific role of 14-3-3s in IR-
induced COP1 nuclear exclusion by irradiating both
HCT116 14-3-3s
+/+ cells and isogenic 14-3-3s-null
(HCT116 14-3-3s
-/-) cells. The loss of 14-3-3s severely
impaired IR-induced COP1 shuttling from the nucleus
to the cytoplasm (Figure 2A). Knockdowns of 14-3-3s
by two distinct shRNAs also compromised IR-induced
COP1 nuclear exclusion when compared with control
cells infected with luciferase shRNA (Figure 2B).
It has been shown that ATM-mediated COP1 serine
387 (S387) phosphorylation leads to IR-induced COP1
nuclear exclusion [9]. To investigate whether 14-3-3s is
involved and whether facilitation of COP1 cytoplasmic
translocation by 14-3-3s is dependent on S387 phos-
phorylation, we constructed the S387A mutant of
COP1. Figure 2C shows that the S387A mutation inhi-
bits the increase of COP1 in the cytoplasm after Ad-14-
3-3s infection in response to DNA damage, suggesting
that 14-3-3s-mediated COP1 nuclear export is depen-
dent on S387 phosphorylation of COP1. Next we used
confocal microscopy to demonstrate that GFP-COP1
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Page 2 of 11dynamic shuttling between the nucleus and the cyto-
plasm in cells cotransfected with 14-3-3s is inhibited,
with most GFP-COP1 accumulating in the cytoplasm
(Figure 2D). On the contrary, the dynamic shuttling of
GFP-COP1 (S378A) was resistant to the nuclear-export
effect of 14-3-3s expression, with most of the GFP-
COP1 located in the nucleus (Figure 2D). Together,
these results suggest that 14-3-3s has an essential role
in mediating IR-induced COP1 nuclear exclusion after
COP1 phosphorylation at S387.
Figure 1 14-3-3s is involved in DNA damage -induced COP1 nuclear exclusion. (A) Live-cell imaging of NIH3T3 cells expressing RFP-COP1.
Typical subcellular localization of RFP-COP1 (red, indicated by arrow) is shown. Hoechst 33342 (0.04 μg/mL) was added for DNA staining (blue).
Merged image containing phase-contrast image is also indicated. Scale bar, 10 μm. (B) Dynamic cell shuttling of RFP-COP1 in NIH3T3 cells was
impaired in the presence of 10 Gy ionizing radiation (IR). Images were collected at 20-min intervals. The minutes indicate the elapsed time since
the first picture was taken (30 min after treatment). (C) COP1 cytoplasmic localization is regulated in response to doxorubicin and IR. U2OS cells
stably expressing RFP-COP1 were treated with 10 Gy ionizing radiation (IR) or 1 μg/mL doxorubicin. Subcellular localization of RFP-COP1 is
shown by Western. Lamin B1 was used as the marker of nuclear (N) fraction, while a-tubulin was used as the marker for cytoplasmic (C) fraction.
(D) 14-3-3s inhibits COP1 nuclear shuttling. RFP-COP1-expressing cells were infected with Ad-b-gal or Ad-14-3-3s. Live-cell images were
captured using a confocal microscope at the indicated time points. Arrows indicate the representative COP1 translocation from the cytoplasm to
the nucleus in the Ad-b-gal treatment group and lack of nuclear migration in the Ad-14-3-3s group. Bar graph shows the percentage increase
in nuclear COP1 staining in each group. Error bars represent 95% confidence intervals. Scale bar= 10 μm. Cell fractionation of RFP-COP1 in each
group is shown by Western blot. (N), nuclear fraction. (C), cytoplasmic fraction.
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Page 3 of 11N-terminal 14-3-3s interacts with COP1 and promotes
COP1 nuclear export
An issue is how 14-3-3s regulates the nuclear export of
phosphorylated COP1. We showed that there is an
interaction between endogenous 14-3-3s and COP1 by
reciprocal co-immunoprecipitation (Figure 3A). To
define the 14-3-3s region responsible on 14-3-3s
required for binding to COP1, we performed co-immu-
noprecipitation assays using N and C terminal deletions
constructs of 14-3-3s. We showed that COP1 bound to
the N-terminus of 14-3-3s (aa 1-161) but not the C-ter-
minus (aa 153 - 248) (Figure 3A). These data indicated
that 14-3-3s used its N-terminal region to bind to the
COP1. To investigate whether 14-3-3s associates with
COP1 and utilizes 14-3-3s’s NES for mediating COP1
nuclear export, we have constructed a 14-3-3s NES
(I205A, L208A) mutant [19]. Again, we employed
immunofluorescence microscopy to demonstrate that
GFP-COP1’s dynamic shuttling between the nucleus and
the cytoplasm in GFP-COP1-overexpressing cells
cotransfected with wt 14-3-3s is inhibited by 14-3-3s
expression, with most GFP-COP1 accumulating in the
cytoplasm (Figure 3B). In contrast, the nuclear export of
COP1 was less affected when cells were cotransfected
with RFP-14-3-3s NES (I205A, L208A) mutant, suggest-
ing that the nuclear export signal (NES) of 14-3-3s is
essential for the increase of COP1 in the cytoplasmic
fraction. The bar graph showed that the 14-3-3s NES
mutant had less ability to reduce the nuclear accumula-
tion of COP1 than did the14-3-3s WT.
14-3-3s is a phosphorylated COP1 binding protein
14-3-3 preferentially binds to target proteins with the
RSXpSXP and RXXXpSXP motifs, where pS represents
phosphoserine [22]. We analyzed the COP1 peptide
sequence and found that a putative 14-3-3s binding
motif [11] in COP1 is located at S387 and that this
motif (RTAS
387QL) is evolutionarily conserved in
Figure 2 COP1 S387 phosphorylation is essential for 14-3-3s -induced COP1 nuclear export. (A) Cytoplasmic COP1 localization is
compromised after DNA damage in 14-3-3s-null cells. HCT116 14-3-3s
+/+ and HCT116 14-3-3s
-/-cells were treated with 10 Gy IR. Cytoplasmic
and nuclear extracts were prepared 2 hr after irradiation. N, nuclear fraction. C, cytoplasmic fraction. (B) Cytoplasmic COP1 localization is reduced
in 14-3-3s knockdown cells after IR. HCT116 cells were stably transfected with two specific 14-3-3s shRNA (1 & 2). Luciferase shRNA was used as
a control (C). Cytoplasmic and nuclear extracts were prepared 2 hours after cells were treated with 10 Gy IR. (C) COP1 S387 mutant is less
sequestered by 14-3-3s in the cytoplasm in response to DNA damage. HEK 293 cells were transfected with Flag-COP1 (WT), or Flag-COP1 (387A),
followed by infection with Ad-b-gal or Ad-14-3-3s. Lysates were immunoblotted with anti-Flag. Cytoplasmic and nuclear extracts were prepared
2 hr after cells were treated with 10 Gy IR. (D) 14-3-3s-induced COP1 cytoplasmic translocation is S387 phosphorylation-dependent. U2OS cells
were transfected with the indicated plasmids. GFP-COP1 localization of live cell images were captured using a confocal microscope. Arrows
indicate the representative location of COP1 in the nucleus. The bar graph shows the percentage of COP1 localized in the nucleus from each
group. Scale bar, 10 μm.
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Page 4 of 11mammals (Figure 4A). We hypothesized that phosphory-
lation of COP1 is required for the interaction between
14-3-3s and COP1. To address this issue, we prepared
lysates from cells stably expressing Flag-COP1 with or
without phosphatase inhibitors (sodium fluoride and
sodium orthovanadate). The level of binding between
14-3-3s and COP1 was lower in the absence of phos-
phatase inhibitors than the level of binding in their pre-
sence (Figure 4B), suggesting that phosphorylation is
required for binding. To further demonstrate whether
ATM-mediated phosphorylation on COP1 is important
for 14-3-3s binding, we investigated the binding
between 14-3-3s and COP1 while modulating ATM sta-
tus (Figure 4C). AT22IJE-T cells [ataxia-telangiectasia
mutated protein (ATM)
-/- fibroblasts] and AT22IJE-
TpEBS7-YZ5 cells (ATM
-/- fibroblasts complemented
with ATM cDNA) [23] were used in these experiments.
We found that binding between 14-3-3s and COP1 was
increased in the presence of ATM following DNA
damage but this binding was abolished in ATM deficient
(ATM
-/-) cells [23] (Figure 4C). Since S387 is an ATM
phosphorylation site and the level of binding between
14-3-3s and COP1 was higher in the presence of phos-
phatase inhibitors (Figure 4B), we predicted that the
abolishment of COP1 S387 phosphorylation by mutating
serine to alanine would interfere with 14-3-3s-COP1
binding. Coimmunoprecipitation showed that the COP1
(S387A) mutant lost its binding affinity for 14-3-3s (Fig-
ure 4D). These results indicate that COP1 S387 phos-
phorylation is required for COP1-14-3-3s binding.
Phosphorylation of COP1 on S387 is critical for 14-3-3s
-mediated COP1 degradation
Our findings that the COP1 (S387A) mutant lost its affi-
nity for 14-3-3s (Figure 4D) imply that the COP1
(S387A) mutant is resistant to 14-3-3s-induced
Figure 3 14-3-3s binds Cop1 and induces COP1 nuclear export via its NES. (A) Identification of 14-3-3s domain that interactions with
COP1. 293T cells were cotransfected with Myc-COP1 and Flag-14-3-3s wild type (WT) (aa 1-248), N-terminal (aa 1-161) or C-terminal (aa 153-248).
Before harvesting, cells were treated with proteasome inhibitors. Lysates were immunoprecipitated with anti-Myc and immunoblotted with anti-
Flag. Specific interactions of 14-3-3s domains with COP1 are indicated. Asterisks indicate IgG light chain. WCL, whole cell lysate. (B) 14-3-3s
nuclear export signal (NES) mutant is unable to mediate cytoplasmic accumulation of COP1. U2OS cells were cotransfected as indicated with
GFP-COP1, Flag-14-3-3s wild type (WT), or RFP-14-3-3s NES (I205A, L208A) mutant. Live-cell images of GFP-COP1 localization were captured
using a fluorescence microscope. The bar graph shows quantification of the nuclear localization of COP1. Error bars represent 95% confidence
intervals. Scale bar, 10 μm.
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Page 5 of 11degradation via the polyubiquitination-proteasomal
pathway. Indeed, we showed that 14-3-3s decreased the
steady-state level of wild-type COP1 protein in a dose-
dependent manner, while the steady state expression of
COP1 (S387A) mutant is not affected by the expression
of 14-3-3s (Figure 5A). Consistently, we showed that
14-3-3s expression had an impact on the turnover rate
of COP1 but had no effect in increasing the turnover of
COP1 (S387A) mutant (Figure 5B). Accordingly, the
ubiquitination level of COP1 was increased by cotrans-
fection of 14-3-3s (Figure 5C), while COP1 (S387A)
mutant was resistant to 14-3-3s-induced COP1 polyubi-
quitination (Figure 5C). Given that 14-3-3s has a role in
COP1 nuclear exclusion (Figure 1) and is facilitating
COP1 ubiquitination, we further addressed whether
cytoplasmic COP1 ubiquitination increases upon DNA
damage and whether such a process is facilitated by14-
3-3s. More cytoplasmic polyubiquitinated COP1 was
detected in HCT116 14-3-3s
+/+ cells treated with 10 Gy
IR compared with no IR treatment (Figure 5D, lanes 1
and 2). Importantly such an increase in cytoplasmic
polyubiquitinated COP1 was compromised in the
absence of 14-3-3s (Figure 5D, lanes 3 and 4). These
data strongly suggest that ATM-induced COP1S387
phosphorylation is essential for 14-3-3s-mediated COP1
degradation via the ubiquitin-proteasomal pathway.
14-3-3s antagonizes COP1-mediated p53 nuclear export
It is well known that COP1 is involved in p53 ubiquiti-
nation but it remains unknown whether COP1 can reg-
ulate p53 nuclear export. To address this question, we
employed immunofluoroscence microscopy and found
that RFP-COP1 expression in the cell led to nuclear
export of GFP-p53 (Figure 6A) in H1299 (p53 Null)
cells. Given that 14-3-3s has a role in COP1 nuclear
exclusion (Figure 1) and mediates COP1 downregulation
(Figure 5), we further investigated COP1-mediated p53
nuclear export in the presence of 14-3-3s and showed
that COP1-mediated p53 nuclear export is antagonized
by 14-3-3s (Figure 6A).
It has been shown that MDM2 can cause p53 nuclear
export; therefore, it raises the question whether COP1-
mediated p53 nuclear export is through uncharacterized
activity on MDM2. To exclude the contribution of
MDM2, we performed the experiments described above
by cotransfecting RFP-COP1 with GFP-p53 into p53
-/-
MDM2
-/- MEF cells. Our results show that RFP-COP1
expression still caused nuclear export of GFP-p53 in
Figure 4 14-3-3s binds phosphorylated COP1. (A) The consensus 14-3-3 binding motif is highlighted. Sequences of COP1 and other known
14-3-3 substrates are shown for comparison. Sequence alignment of COP1 containing 14-3-3 binding motifs from different species is shown in
right panel. (B) Binding between 14-3-3s and COP1 is phosphorylation-dependent. Lysates of U2OS cells stably expressing Flag-COP1 were
treated with or without sodium fluoride and sodium orthovanadate. Before harvesting, cells were treated with MG132. Lysates were incubated
with purified GST-14-3-3s or GST and immunoblotted with anti-Flag. PD: pull down. (C) ATM facilitates the binding between 14-3-3s and COP1.
AT22IJE-T/pEBS7 (ATM
-/-) and AT22IJE-T/YZ5 (ATM
+/+) cells were treated with MG132 for 6 hrs before harvesting and were prepared at 0 (-) and 1
hr (+) after cells were treated with 10 Gy IR. Lysates were immunoprecipitated with anti-14-3-3s and immunoblotted with anti-COP1. (D) COP1
(S387A) abolished binding to14-3-3s in vivo. 293T cells were transfected with Myc-COP1 (WT [wild type]), Myc-COP1 (S387A) or Flag-14-3-3s.
Lysates were immunoprecipitated with anti-Myc and immunoblotted with anti-Flag.
Su et al. Molecular Cancer 2010, 9:243
http://www.molecular-cancer.com/content/9/1/243
Page 6 of 11p53
-/- MDM2
-/- MEF cells (Figure 6B), suggesting that
COP1’s function is independent of MDM2. Further,
COP1-mediated p53 nuclear export is again hindered by
14-3-3s in such a context (Figure 6B). Together, these
results show that 14-3-3s’s impact on COP1 nuclear
export (Figure 1) is also translated into preventing
COP1-mediated p53 nuclear export.
Discussion
The dynamic cytoplasm/nucleus distribution of COP1 is
important for its function. In plants, the major purpose
of COP1’s nuclear import is to function as a master reg-
ulator of nuclear transcription regulator HY5 [24,25], a
positive regulator of photomorphogenic development. In
mammalian cells, one of COP1’s nuclear targets is p53,
but the biological consequence of cytoplasmic distribu-
tion of COP1 is not well characterized.
Here we are able to provide important insights. First,
we have shown that IR induces cytoplasmic distribution
of COP1 (Figure 1) and facilitates COP1 cytoplasmic
ubiquitination (Figure 5D) and that 14-3-3s is essential
for increasing DNA damageinduced cytoplasmic ubiqui-
tination of COP1 as this activity is compromised by 14-
3-3s deficiency (Figure 5D). This 14-3-3s-COP1 link
fits very well with the notion that the inhibition of p53
E3 ligases is an important step for p53 stabilization after
DNA damage. Second, we have shown that the N-term-
inal portion of 14-3-3s interacts with COP1 (Figure 3)
and that 14-3-3s causes the nuclear export of COP1
through its leucine-rich nuclear export signal sequence
Figure 5 Phosphorylation of COP1 at S387 is important for 14-3-3s-mediated COP1 Degradation. (A) 14-3-3s downregulates steady-state
expression of COP1 (WT) but has no impact on COP1 (S387A). 293T cells were cotransfected with the indicated Flag-COP1 (WT), Flag- COP1
(S387A) and Flag-14-3-3s. Cell lysates were immunoblotted with anti-Flag and anti-tubulin. (B) 14-3-3s increases turnover rate of COP1 (WT) but
has no impact on COP1 (S387A).293T cells were cotransfected with indicated plasmids. Before harvesting, cells were treated with cycloheximide
(CHX) for the indicated times. Cell lysates were immunoblotted with anti-Flag and anti-tubulin. Turnover rate of COP1 is indicated as a bar
graph. (C) 14-3-3s promotes COP1 (WT) polyubiquitination but has no effect on COP1 (S387A).293T cells were cotransfected as indicated with
Myc-COP1 (WT), Myc-COP1 (S387A) or Flag-14-3-3s. Cells were treated with MG132 for 6 hrs before harvesting. Ubiquitinated COP1 was
immunoprecipitated with anti-Myc and immunoblotted with anti-HA. Equal amounts of whole cell lysate were immunoblotted with anti-Myc,
anti-Flag or anti-tubulin. (D) 14-3-3s promotes cytoplasmic COP1 polyubiquitination in response to DNA damage. HCT116 14-3-3s
+/+ (lanes 1
and 2) and HCT116 14-3-3s
-/- (lanes 3 and 4) were treated with MG132 for 6 hrs before harvesting. Cytoplasmic extracts were prepared at 0 and
2 hr after cells were treated with 10 Gy IR. Cytoplasmic polyubiquitinated COP1 was detected by immunoprecipitation with anti-COP1 and
immunoblotting with anti-ubiquitin in indicated cells.
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Page 7 of 11[19], since the 14-3-3s NES mutant loses the ability to
export COP1. This observation is reminiscent of 14-3-
3s’s impact on nuclear export of Cdc2 and Cdk2
[19,21]. It is important to point out that little is known
about what signals or mediators control the subcellular
localization of COP1. Our discovery of 14-3-3s’sr o l ei n
mediating COP1 nuclear export has filled this gap in
knowledge. Third, ATM-mediated phosphorylation of
COP1 at S387 promotes COP1’s binding to 14-3-3s
(Figure 4C). Significantly, the interaction of COP1 with
14-3-3s is important for facilitating COP1 to stay in the
cytoplasm since the COP1 (S387A) mutant, which also
lost the characteristic to bind 14-3-3s, is resistant to 14-
3-3s-mediated nuclear export (Figure 2D). Therefore,
both ATM and 14-3-3s are involved in regulating
COP1 subcellular localization. Given that 14-3-3s is
also an important regulator for kinases [19,21], whether
14-3-3s synergize with ATM to reinforce the 14-3-3s-
COP1 interaction will be another interesting layer of regu-
lation to explore in the future. Lastly, we demonstrate for
the first time that COP1 is able to cause p53 nuclear
export (Figure 6), and this process is MDM2-independent
(Figure 6B). Further, COP1’s mediation of p53 nuclear
export can still be inhibited by the expression of 14-3-3s
(Figure 6B). Because the mechanism behind COP1-
mediated p53 nuclear export remains unknown, it is not
clear how the nuclear COP1 binds p53 to regulate p53
nuclear export in the presence of 14-3-3s. It is possible
that 14-3-3s binds to COP1 in the nucleus, and this bind-
ing changes the conformation and thus masks COP1’s
capability to export p53. Further investigation will provide
the insight into this regulation. Taken together, these data
suggest that the COP1 axis is independent of the MDM2
axis in terms of regulating p53 nuclear export.
It is important to point out that 14-3-3s regulates
both the MDM2-p53 axis (our previous study) [16] and
Figure 6 14-3-3s blocks COP1-mediated p53 nuclear export regardless of MDM2 status. (A) 14-3-3s blocks COP1-mediated p53 nuclear
export. H1299 cells were cotransfected as indicated with RFP-COP1, GFP-p53 or Flag-14-3-3s. Live-cell images were captured using a
fluorescence microscope 1 day after transfection. The bar graph shows quantification of nuclear p53 localization. Error bars represent 95%
confidence intervals. Scale bar, 10 μm. (B) p53
-/- MDM2
-/- MEF cells were cotransfected with the indicated plasmids. Live-cell images were
captured using a fluorescence microscope 1 day after transfection as described in (A). The bar graph shows quantification of nuclear p53
localization. Error bars represent 95% confidence intervals. Scale bar, 10 μm.
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Page 8 of 11the COP1-p53 axis (this study). Although the detailed
mechanisms of COP1-mediated p53 nuclear export
remain to be characterized, these findings highlight the
complexity of the p53 nuclear export process and
demonstrate that 14-3-3s exerts negative impact on two
p53 ubiquitin ligases to stabilize p53.
Conclusion
On the basis of this study, we can now depict a model
of COP1 regulation by 14-3-3s (Figure 7). In unstressed
cells, COP1 is mainly localized in the nucleus [9]. Upon
DNA damage and ATM activation, COP1 is phosphory-
lated and binds to 14-3-3s through a phosphoserine
motif at S387, which is required for COP1 translocation
to the cytoplasm (nuclear export). Eventually, cytoplas-
mic COP1 ubiquitination is enhanced, resulting in pro-
teasomal degradation. Reducing amounts of COP1
compromises its ability to mediate p53 nuclear export,
thus stabilizing p53. While ATM, 14-3-3s,a n dp 5 3a r e
all known to be involved in the DNA damage response,
details regarding the molecular mechanism of their
impacts on regulating COP1 and the biological signifi-
cance of this regulation are missing. This report fills this
gap in knowledge by characterizing the molecular
mechanism of the ATM-14-3-3s axis in regulating
COP1 subcellular compartmentalization, and COP1 pro-
tein stability. Therefore, our research paves the path to
future investigation of the 14-3- 3s - C O P 1a x i sa sa
potential therapeutic target for novel anticancer
therapies.
Materials and methods
Cell culture and reagents
Human 293T, H1299, AT22IJE-T/pEBS7 (ATM
-/-),
AT22IJE-T/YZ5 (ATM
+/+)a n d( p 5 3
-/-,M D M 2
-/-)M E F
cells were cultured in DMEM/F12 medium supplemen-
ted with 10% fetal bovine serum. AT22IJE-T cells
[ataxia-telangiectasia mutated protein (ATM)
-/- fibro-
blasts] and AT22IJE-TpEBS7-YZ5 cells (ATM
+/+,
ATM
-/- fibroblasts complemented with ATM cDNA)
[23] were gifts from Dr. Y. Shiloh (Tel Aviv University,
Tel Aviv, Israel). HCT116 and U2OS cells were main-
tained in McCoy’s 5A medium. For transient
transfection, cells were transfected with DNA using
either Lipofectamine 2000 (Invitrogen), or FuGENE HD
(Roche) reagents.
Plasmids, reagents and antibodies
N-terminal Flag-14-3-3s (1-161), and C-terminal Flag-
14-3-3s (153-248) have been previously described [17].
RFP-14-3-3s or RFP-COP1 was cloned into pdsRed1-C1
vector. RFP-14-3-3s (NES I205A, L208A) mutant [19],
GFP-COP1 (S387A) or Flag- COP1 (S387A) was con-
structed by PCR cloning. Ad-14-3-3s and Ad-b-gal
viruses [20] were produced as previously described [18].
GFP-p53 was kindly provided by Dr G. Wahl [26]. GFP-
MDM2 was a kind gift from Dr Sudha Shenoy. Antibo-
dies were purchased from the indicated vendors: Flag
(M2 monoclonal antibody, Sigma), tubulin (Sigma),
COP1 (Bethyl Laboratories), 14-3-3s RDI), Myc (mouse
monoclonal 9E10, Santa Cruz Biotechnology; rabbit
polyclonal, Sigma), HA (12CA5, Roche), His (Cell Sig-
naling), ubiquitin (Zymed Laboratories, Inc.) and Lamin
B1 (Abcam).
Generation of stable transfectants
For generation of 14-3-3s knockdown stable cell lines,
HCT116 cells were infected with Mission lentiviral
shRNA transduction particles (Sigma) containing either
control shRNA, 14-3-3s shRNA (1) (5′-CCGGC
CGGGT CTTCT ACCTG AAGAT CTCGA GATCT
TCAGG TAGAA GACCC GGTTT TTG) or 14-3-3s
shRNA (2) (5′-CCGGG ACGAC AAGAA GCGCA
TCATT CTCGA GAATG ATGCG CTTCTT GTCGT
CTTTT TG). After infection, cells were selected with 2
μg/mL puromycin for 2 weeks.
For generation of RFP-tagged-COP1 (RFP-COP1)
overexpression stable transfectants, U2OS cells or NIH
3T3 cells were transfected with RFP vector or RFP-
COP1 plasmids by electroporation (Amaxa). Forty-eight
hours after transfection, cells were selected in a culture
medium containing 500 μg/mL G418 for 4 weeks.
Cell fractionation
Cells were lysed in lysis buffer (10 mM Tris, pH 7.6, 10
mM MgCl2,1μM DTT, 0.5% NP-40, phosphatase
Figure 7 The working model of 14-3-3s-mediated COP1 nuclear export under DNA damage.
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Page 9 of 11inhibitors and protease inhibitors), incubated on ice for
30 min, and homogenized by 20 strokes in a glass
homogenizer. The homogenate was centrifuged at 4000
rpm for 5 min to sediment the nuclei. The supernatant
was then centrifuged at 13,200 rpm for 10 min, and the
resulting supernatant was used as the cytosolic fraction.
The nuclear pellet was washed three times and resus-
pended in regular lysis buffer to extract nuclear pro-
teins. The extracted material was centrifuged at 16,100 g
for 20 min, and the resulting supernatant was used as
the nuclear fraction.
Live-cell imaging
RFP-COP1-expressing cells were treated with DNA
damaging agents, including 1 μg/mL doxorubicin and
10 Gy IR, or infected with Ad-b-gal (multiplicity of
infection [MOI] = 100) or Ad-14-3-3s (MOI = 100).
Live images of cells stably expressing RFP-COP1 were
captured with an Olympus FV300 microscope or Zeiss
Axiovert 200 M microscope. DNA staining was per-
formed with 0.04 μg/mL Hoechst 33342.
Immunoprecipitation and immunoblotting
Total cell lysates were solubilized in lysis buffer and
processed as previously described [19]. Lysates were
immunoprecipitated with indicated antibodies. Proteins
were resolved by SDS-PAGE gels and proteins trans-
ferred to polyvinylidene difluoride membranes (Milli-
pore). Membranes were washed and incubated with
primary antibodies and peroxidase-conjugated secondary
antibodies (Thermo Scientific). Chemiluminescent
images of immunodetected bands were recorded on X-
ray films using the enhanced chemiluminescence (ECL)
system (Roche).
Ubiquitination assay
293T cells were transiently cotransfected with indicated
plasmids to detect exogenous COP1 ubiquitination.
HCT116 14-3-3s
-/-and 14-3-3s
+/+ cells were used to
detect endogenous COP1 ubiquitination. Cells were
treated with 5 μg/mL MG132 (Sigma) for 6 hrs before
harvesting. Cells were harvested and lysed with lysis buf-
fer described above. Ubiquitinated COP1 was immuno-
precipitated with anti-Myc (9E10, Santa Cruz
Biotechnology) or anti-COP1 (Bethyl Laboratories) and
immunoblotted with anti-HA (Roche) or anti-ubiquitin
(Zymed Laboratories).
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